INTRODUCTION
============

Signal transduction, whereby a cell receives and processes extracellular information to coordinate a cellular process, is critical for normal cell function. Signal-transduction systems are commonly perturbed in disease, making core constituents (e.g., kinases) attractive therapeutic targets ([@B36]). While we have learned a great deal about the components of key signaling pathways, the complex nature of these vast networks represents a significant obstacle to understand their dynamics, regulation, and function. Systems biology and computational modeling of biological systems have become increasingly valuable in enhancing our understanding of these complex protein interaction networks.

Systems biology involves the study of the complex interactions and associated dynamics found in biological systems. Systems biology approaches commonly involve translation of the system into a mathematical model for subsequent computer simulation and analysis. As systems-based approaches have gained favor in the study of human disease processes, so has mathematical modeling of biological systems with associated advancements in understanding complex biological phenomenon like circadian rhythms, apoptosis, synaptic plasticity, and cell communication ([@B21]; [@B29]).

The multifunctional Ca^2+^/calmodulin-dependent protein kinase II (CaMKII) has emerged as an attractive target for systems-based approaches that aim to integrate large experimental data with mathematical modeling and computational approaches across spatial and temporal scales (**Figure [1](#F1){ref-type="fig"}**). CaMKII serves as a nodal point for a vast signaling network that regulates critical processes like learning and memory, cardiomyocyte contractility, T-cell selection, and expression and localization of class II MHC molecules in dendritic cells ([@B2]; [@B42]; [@B43]; [@B20]; [@B1]; [@B58]). For example, CaMKII regulates multiple important functions in neurons, including synthesis and release of neurotransmitters, modulation of ion channel activity, neurite extension, synaptic plasticity, learning, and gene expression ([@B2]). Similarly, in heart, CaMKII phosphorylates ion channels, transcription factors, signaling molecules, and other membrane proteins that are critical to cardiac electrical activity and structure. Abnormal CaMKII activity has been observed in human and animal models of cardiovascular disease (e.g., heart failure, myocardial infarction, arrhythmia), and is thought to promote downstream dysfunction in excitation-contraction coupling, structural remodeling, cell death, and even transcriptional activation of inflammation factors ([@B42]; [@B58]). Current research aims at elucidating how this large effector molecule acts as a pro-cardiac disease/arrhythmogenic molecule and whether it may be effectively targeted for therapy.

![**Multi-scalar mathematical modeling of CaMKII signaling.** **(A--D)** Mathematical modeling has been applied to understand CaMKII function across scales from the molecular to the tissue level. Each scale presents unique challenges and opportunities for modeling efforts. Abbreviations are as follows: *I~Ca~*, L-type Ca^2+^ current; *I~Na~*, fast Na^+^ current; PLB, phospholamban; *I~Up~*, Ca^2+^ uptake into the sarcoplasmic reticulum.](fphar-05-00009-g001){#F1}

Mathematical modeling studies over the past three decades have elucidated important aspects of CaMKII function and signaling mechanisms. Pioneering modeling studies focused on understanding CaMKII structure and function in the brain ([@B37]; [@B38]; [@B18]; [@B9]; [@B32]; [@B12]). This early work motivated later studies that incorporated models of CaMKII activity into models of the whole cell and tissue (mostly cardiac) to understand the larger role of CaMKII signaling in cell/organ function (**Figure [1](#F1){ref-type="fig"}**; [@B25]; [@B26]; [@B16]; [@B39]; [@B23]; [@B52]; [@B8]; [@B27]; [@B19]; [@B48]). Recently, these efforts have been expanded to gain insight into the role of CaMKII in human disease ([@B23]; [@B8]; [@B27]; [@B19]; [@B59]; [@B35]; [@B41]; [@B61]). This review aims at describing the challenges, advances and opportunities for mathematical modeling of CaMKII signaling at each stage of development across scales from the molecular to the tissue level.

MODELING THE CAMKII HOLOENZYME
==============================

The CaMKII holoenzyme possesses a number of distinguishing characteristics that pose unique challenges for modeling. Briefly (details may be found elsewhere ([@B10]; [@B1]; [@B58]), multiple CaMKII isoforms are expressed in cells with CaMKIIα and CaMKIIβ expressed predominantly in neurons, whereas CaMKIIγ and CaMKIIδ are more uniformly expressed in other tissues. Structurally, the CaMKII holoenzyme is organized as a hexamer of dimers arranged as two stacked rings. Each monomer is comprised of an N-terminal catalytic domain, a regulatory domain, and a C-terminal association domain. In its inactive conformation, the regulatory domain binds to the active site in catalytic domain, thereby inhibiting the activity of the enzyme. Association of Ca^2+^ bound calmodulin to the regulatory domain causes its release from the active site and exposes the active site in catalytic subunit, enabling the kinase to phosphorylate its substrates ([@B28]; [@B51]). Multiple residues within the regulatory domain are also exposed that may subsequently undergo post-translational regulation (e.g., phosphorylation, oxidation, glycosylation) that, in turn, alter kinase function ([@B34]; [@B2]; [@B13]; [@B58]; [@B14]). Enzyme regulation/activity depends heavily on the multimeric holoenzyme structure ([@B28]; [@B22]; [@B50]; [@B6]; [@B57]). For example, a distinguishing characteristic is the ability of CaMKII to undergo autophosphorylation where an active (Ca^2+^/calmodulin bound) kinase subunit is phosphorylated at a specific residue (Thr286/287) by a neighboring active subunit ([@B34]; [@B2]). The autophosphorylated kinase retains activity in the absence of bound Ca^2+^/calmodulin and is thought to contribute to synaptic plasticity and learning functions as well as myocyte excitation-contraction coupling ([@B53],[@B54]; [@B12]).

One of the most obvious and compelling challenges for modeling of CaMKII is autoregulation. The simplest models consider the entire population of CaMKII subunits that are subject to autophosphorylation at a rate dependent on levels of Ca^2+^/calmodulin ([@B18]; [@B12]; [@B15]; [@B7]). Detailed models have also been developed that incorporate structural information to account for the fact that CaMKII autophophosphorylation is constrained by physical proximity of active subunits ([@B38]; [@B45]; [@B62]; [@B33]; [@B46]; [@B40]; [@B44]). Recently, efforts have been made to also account for other kinase activation modes (e.g., oxidation; [@B8]). Modeling studies at the molecular level have generated important insight into CaMKII function. In particular, models have been used to demonstrate that CaMKII activity is sensitive to changes in Ca^2+^ spike frequency and is capable of long-term storage of information at the post-synaptic density by acting as a bistable switch ([@B37]; [@B38]; [@B18]; [@B9]; [@B32]; [@B12]). Furthermore, modeling studies have demonstrated the importance of autophosphorylation for bistability in CaMKII signaling, although there is some debate about the requisite conditions and physiological relevance ([@B62]; [@B44]). Together, these initial CaMKII modeling studies provided important insight into the link between holoenzyme structure, the ability of the kinase to encode Ca^2+^spike information, and behavior (e.g., long-term potentiation) in neurons. Moreover, this work laid the essential foundation for subsequent multi-scale studies in other systems (e.g., heart).

MODELING CAMKII SIGNALING IN THE INTACT CELL AND TISSUE
=======================================================

Much work has been done, particularly in the cardiac field, to incorporate models of the CaMKII signaling pathway into models of the intact cell (**Figure [2](#F2){ref-type="fig"}**). Modeling of CaMKII signaling at the cellular level poses a unique set of challenges in addition to those encountered at the molecular level (**Table [1](#T1){ref-type="table"}**). First, the kinase is sensitive to intracellular Ca^2+^, whose temporal and spatial profile is tightly controlled. In the myocyte, for example, influx of Ca^2+^ through voltage-gated Ca^2+^ channels during the action potential (AP) triggers Ca^2+^ release from the sarcoplasmic reticulum (SR) that leads to a large increase in intracellular Ca^2+^(free and calmodulin-bound) levels. Thus, any cell model of the kinase pathway must address the dynamic nature of the input, namely Ca^2+^-bound calmodulin. Second, once activated, the multifunctional kinase targets a large number of substrates in the cell, from membrane ion channels, pumps and transporters to contractile proteins and even transcription factors. One must consider *a priori* which targets are likely important for the phenomenon of interest. Finally, CaMKII interacts with a vast and complex signaling web that includes other proteins directly regulated by Ca^2+^/calmodulin (e.g., ion channels, calcineurin), protein phosphatases that antagonize CaMKII phosphorylation (e.g., PP1), and other kinases that potentially synergize CaMKII effects (e.g., protein kinase A).

![**Mathematical modeling of CaMKII signaling in the intact cell. (A)** Schematic of the Hund-Rudy model of the ventricular action potential that accounts for dynamic CaMKII signaling ([@B8]). Abbreviations are as follows: *I~Na~*, fast Na^+^ current; *I~Na,L~*, late (persistent) Na^+^ current; *I~Ca(L)~*, L-type Ca^2+^ current; *I~NaCa~*, Na^+^/Ca^2+^ exchanger; *I~p(Ca)~*, sarcolemmal Ca^2+^ pump; *I~Ca,b~*, background Ca^2+^ current; *I~Cl,b~*, background Cl^-^ current; *CT~NaCl~*, Na^+^/Cl^-^cotransporter; *CT~KCl~*, K^+^/Cl^-^cotransporter; *I~to1~*, transient outward K^+^ current; *I~to2~*, Ca^2+^-dependent transient outward current; *I~Kr~*, rapid delayed rectifier K^+^ current; *I~Ks~*, slow delayed rectifier K^+^ current; *I~K1~*, inward rectifier K^+^ current; *I~Kp~*, plateau K^+^ current; *I~NaK~*, Na^+^/K^+^ ATPase; *I~K(Na)~*, Na^+^-dependent K^+^ current; *I~K(ATP)~*, ATP-sensitive K^+^ current; *I~rel~*, sarcoplasmic reticulum (SR) ryanodine receptor Ca^2+^ release channel; *I~Up~*, SR Ca^2+^ pump; PLB, phospholamban; *I~leak~*, SR Ca^2+^ leak; NSR, network SR; JSR, junctional SR; *I~tr~*, Ca^2+^ transfer from NSR to JSR. **(B)** State diagram for integrated CaMKII model that includes inactive (I), Ca^2+^/calmodulin bound (B), autophosphorylated (P, OxP) and oxidized active states (Ox, OxP). Abbreviations are as follows: *k~IB~, k~BI~*, forward and reverse rate constants, respectively, for transition from inactive state to Ca^2+^/calmodulin bound state; *k~A~, k~PB~*, autophosphorylation and dephosphorylation rate constants, respectively, for transition from Ca^2+^/calmodulin bound state to autophosphorylated state; *k~A~, k~OxPOx~*, autophosphorylation and dephosphorylation rate constants, respectively, for transition from oxidized active state to oxidized and autophosphorylated state; *k~OxB~, k~BOx~*, forward and reverse rate constants, respectively, for transition fromCa^2+^/calmodulin bound state to oxidized active state; *k~POxP~, k~OxPP~*, forward and reverse rate constants, respectively, for transition from autophosphorylated state to oxidized and autophosphorylated active state. Simulated **(C)** action potentials and **(D)** CaMKII activity from the model at two different pacing frequencies to demonstrate sensitivity of CaMKII to pacing frequency.](fphar-05-00009-g002){#F2}

###### 

Challenges for modeling of CaMKII activity across scales from molecule to tissue.

  Scale          Challenges for modeling                                                                                       Representative models
  -------------- ------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------
  Molecule       Regulation by Ca^2+^/calmodulin and post-translational modification (including autophosphorylation).          [@B18], [@B9], [@B12], [@B15].
                 Complex structure/function relationship.                                                                      [@B38], [@B45], [@B62], [@B33], [@B46], [@B40], [@B44].
  Cell           Dynamic Ca^2+^ signaling as input. Large number of substrates. Resides at center of vast signaling network.   [@B25], [@B26], [@B16], [@B39], [@B7], [@B52], [@B55], [@B11], [@B48].
                 Chronic vs. acute effects of CaMKII activation.                                                               [@B23], [@B27], [@B19], [@B35], [@B61].
  Tissue/organ   Chronic and acute remodeling in disease.                                                                      [@B8], [@B58], [@B41].

Despite these numerous obstacles, CaMKII signaling networks have been successfully incorporated with varying degrees of complexity into whole cell models of the myocyte (mostly ventricular) action potential and calcium transient ([@B25]; [@B26]; [@B16]; [@B39]; [@B23]; [@B52]; [@B8]; [@B27]; [@B19]; [@B48]), as well as other non-cardiac cell types ([@B11]; [@B47]). These models have employed different strategies to deal with challenges outlined above. The most common class of models incorporate a scheme where a single population of CaMKII responds to changes in bulk or subspace Ca^2+^/calmodulin ([@B25]; [@B26]; [@B39]; [@B23]). In other cases, a static formalism is adopted where CaMKII-dependent effects on membrane substrates are implemented in the absence of dynamic changes in CaMKII activity ([@B16]; [@B60]; [@B30]; [@B31]). More recently, consideration has been given to compartmentalization of CaMKII signaling within the cell ([@B52]; [@B56]; [@B55]). In general, models account for CaMKII-dependent effects on membrane ion channels and transporters important for Ca^2+^ cycling, including the ryanodine receptor (RyR), SERCA 2a (SR Ca^2+^ ATPase), phospholamban (PLB), and L-type Ca^2+^ channels. As data have emerged regarding CaMKII-dependent effects on other channels important for the action potential (e.g., *I~Na~* and *I~to~*), these effects have also been incorporated ([@B16]; [@B23]; [@B8]; [@B19]; [@B31]). It is expected that as we learn more about the specific molecular targets for CaMKII within the cell, models will adapt to account for the new findings.

What have we learned from cellular models of CaMKII signaling? Several computational studies have demonstrated the ability of CaMKII to regulate myocyte action potential, Ca^2+^ transient, and even contractile force in a rate-dependent manner ([@B25]; [@B26]; [@B39]; [@B55]; [@B48]). Interestingly, a role for CaMKII has emerged not only in normal rate dependent behavior (e.g., AP duration adaptation and force-frequency relationships), but also in promoting cellular triggers for arrhythmias such as AP alternans and afterdepolarizations ([@B16]; [@B39]; [@B60]; [@B19]; [@B30]; [@B55]). Integrated myocyte models have also been applied to increase our understanding of spatial and temporal control of CaMKII signaling ([@B52]; [@B56]; [@B55]). Interestingly, studies in this area have demonstrated the importance of affinity for Ca^2+^/calmodulin in defining the differential response of CaMKII and the protein phosphatase calcineurin to the dynamic Ca^2+^ transient ([@B52]; [@B56]). Furthermore, studies that incorporate both CaMKII and PKA signaling have shown how the two networks synergize for joint regulation of excitation-contraction coupling ([@B55]). It will be interesting, going forward, to model how other factors such as interaction with scaffolding/anchoring proteins (e.g., β~IV~-spectrin) may contribute to spatial control of CaMKII signaling ([@B24]; [@B30]), similar to studies involving other signaling networks ([@B5]; [@B17]). Finally, although considerable less work has been done in this area compared to smaller scales, progress has been made to understand the role of CaMKII in coordinating function at the tissue/organ level ([@B39]; [@B8]; [@B59]; [@B41]). These multicellular studies have identified roles for CaMKII in regulating AP heterogeneity and conduction, as well as cardiac pacemaking.

MODELING CAMKII SIGNALING IN DISEASE
====================================

CaMKII plays a critical role in regulating the substrate for both electrical and mechanical dysfunction in cardiovascular disease ([@B1]; [@B58]). Perhaps the greatest challenge for mathematical modeling of CaMKII signaling is how to ultimately link function at the molecular level to behavior at cell/tissue level in the setting of disease. Among the difficulties for modeling in this area involves distinguishing between acute and chronic effects of CaMKII activity. For example, while acute effects of CaMKII are mostly mediated by posttranslational modification of substrates, chronic CaMKII activation may facilitate large scale remodeling changes due to effects on transcription and gene expression ([@B27]; [@B58]). Mathematical modeling and computer simulation have been used to generate new insights into molecular mechanisms for arrhythmia in several disease states, including myocardial ischemia/infarction, heart failure, and diabetes ([@B23]; [@B8]; [@B59]; [@B35]; [@B41]; [@B61]).

Arrhythmia mechanisms in the canine infarct border zone have been studied extensively using a mathematical modeling approach ([@B3]; [@B4]; [@B23]; [@B8]). The canine infarct border zone is particularly well suited to mathematical modeling approach due to the tremendous amount of available data at the molecular, cellular, and tissue level ([@B49]). Mathematical models have been used to link defects in CaMKII signaling with ion channel remodeling, abnormal Ca^2+^ handling, and arrhythmias in the infarct border zone. Specifically these studies have demonstrated that increased autophosphorylation and oxidation of the kinase results in increased activity that both increases Ca^2+^ leak from the sarcoplasmic reticulum and compromises availability of voltagegated Na^+^ channels to create a favorable substrate for arrhythmias ([@B23]; [@B8]). More recently, mathematical models have been used to study the role of chronic CaMKII activation in sinus node dysfunction in the setting of heart failure and diabetes ([@B59]; [@B41]). A two dimensional model of the intact sinus node has been applied to demonstrate that CaMKII-induced apoptosis and associated loss of sinoatrial node cells disrupts the source--sink balance between the sinoatrial node and surrounding atrial myocardium resulting in slowed pacemaking and even failure ([@B59]; [@B41]). Other studies have used mathematical modeling to determine relative importance of direct CaMKII effects and compensatory changes in gene regulation in the setting of chronic CaMKII overexpression ([@B27]). Finally, in addition to common forms of acquired disease (e.g., myocardial infarction, heart failure, diabetes), mathematical models have been used to better understand the role of CaMKII in congenital disease ([@B60]; [@B31]). A recent study used mathematical modeling to demonstrate that human variants identified in the CaMKII phosphorylation motif of Na~v~1.5 confer arrhythmia susceptibility by mimicking the phosphorylated channel ([@B31]), while an earlier study examined the role of CaMKII regulation of SR Ca^2+^ release in increased incidence of afterdepolarizations in Timothy syndrome ([@B60]). Together these studies demonstrate the potential for mathematical modeling and computer simulation in advancing our understanding of CaMKII biology and its role over a broad range of cardiovascular disease.

FUTURE DIRECTIONS
=================

This review has outlined the many unique challenges and opportunities for multiscale mathematical modeling of CaMKII signaling. While great strides have been made in development and application of mathematical models of CaMKII signaling from molecule to tissue, clearly there are outstanding issues and unanswered questions to be addressed by future research in this area. At the molecular level, the recent discovery of the CaMKII crystal structure represents an exciting development with great potential for modeling ([@B6]). Similarly, it will be important for future modeling efforts to address novel pathways for regulation of CaMKII activity (e.g., glycosylation). At the cell level, a daunting challenge remains the sheer number of targets for CaMKII within the cell, with new substrates identified every year. Moreover, it remains to be understood the "tipping point" from the adaptive to the maladaptive aspects of CaMKII signaling. Finally, while most models have focused on the ventricular myocyte as a system, clearly CaMKII has important roles in other heart regions/cell types (e.g., atrial, sinoatrial node cells). Models of these different cell types that incorporate cell-specific CaMKII signaling will be of great use for studying CaMKII signaling at the organ level.
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